Clinical Trials
7 trialsNCT02489903 2025-03-17
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
Phase 2 Completed
NCT04789941 2021-03-10
How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix
Assiut University
Phase 2 Unknown
NCT01091259 2015-11-24
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
NYU Langone Health
Phase 2 Completed
NCT00136955 2015-06-19
Irinotecan Study For Cervical Cancer
Pfizer
Phase 2 Completed
NCT00053833 2013-11-08
S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
SWOG Cancer Research Network
Phase 2 Terminated
NCT00003345 2013-06-21
Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00106262 2007-04-18
Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer
Women and Infants Hospital of Rhode Island
Phase 2 Terminated